Abstract
Steroid-based drugs are now mainly produced by the microbial transformation of phytosterol, and a two-step bioprocess is adopted to reach high space–time yields, but byproducts are frequently observed during the bioprocessing. In this study, the catabolic switch between the C19- and C22-steroidal subpathways was investigated in resting cells of Mycobacterium neoaurum NRRL B-3805, and a dose-dependent transcriptional response toward the induction of phytosterol with increased concentrations was found in the putative node enzymes including ChoM2, KstD1, OpccR, Sal, and Hsd4A. Aldolase Sal presented a dominant role in the C22 steroidal side-chain cleavage, and the byproduct was eliminated after sequential deletion of opccR and sal. Meanwhile, the molar yield of androst-1,4-diene-3,17-dione (ADD) was increased from 59.4 to 71.3%. With the regard of insufficient activity of rate-limiting enzymes may also cause byproduct accumulation, a chromosomal integration platform for target gene overexpression was established supported by a strong promoter L2 combined with site-specific recombination in the engineered cell. Rate-limiting steps of ADD bioconversion were further characterized and overcome. Overexpression of the kstD1 gene further strengthened the bioconversion from AD to ADD. After subsequential optimization of the bioconversion system, the directed biotransformation route was developed and allowed up to 82.0% molar yield with a space–time yield of 4.22 g·L−1·day−1. The catabolic diversion elements and the genetic overexpression tools as confirmed and developed in present study offer new ideas of M. neoaurum cell factory development for directed biotransformation for C19- and C22-steroidal drug intermediates from phytosterol.
Key points
• Resting cells exhibited a catabolic switch between the C19- and C22-steroidal subpathways.
• The C22-steroidal byproduct was eliminated after sequential deletion of opccR and sal.
• Rate-limiting steps were overcome by promoter engineering and chromosomal integration.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The large family of steroids includes numerous active pharmaceutical ingredients that are widely used in medicine, with immunomodulatory, diuretic, anti-inflammatory, antitumor, and contraceptive effects (Donova and Egorova 2012; Gupta and Mahajan 2019). Instead of the traditional chemical route, which often involves toxic heavy metal catalysts, microbial biotransformation of phytosterol has become a dominant route for the synthesis of steroidal intermediates in recent years. Some strains of the genus Mycolicibacterium (basonym: Mycobacterium) can utilize phytosterol as the sole carbon source by truncating the side chain and modifying the gonane nucleus (Donova et al. 2005; Sukhodolskaya et al. 2007; Zhao et al. 2021). The key enzymes involved in the phytosterol degradation pathway were gradually characterized (Fernandez-Cabezon et al. 2017; Kreit 2019). Combined with advanced target gene deletion methods (Yao et al. 2013), steroidal intermediates with specific structural modification could be simply obtained by one-step biotransformation using bioengineered M. neoaurum strains (Su et al. 2018; Xiong et al. 2020).
The well-recognized industrial strain M. neoaurum NRRL B-3805, which is characterized by its outstanding capability of sterol C19 side-chain cleavage, has been widely applied in the industrial biosynthesis of 4-androstene-3,17-dione (AD) and 1,4-androstediene-3,17-dione (ADD) (Mancilla et al. 2018). A two-step biotransformation process is usually adopted using resting cells as biocatalysts, with advantages including non-sterile conditions, convenient product separation, and high volumetric productivities (Chang et al. 2020; Liu et al. 2018). With the aim of high productivity and simple downstream processing, previous efforts were mainly devoted to the optimization of fermentation/biotransformation conditions, including parameters such as dissolved oxygen (Zhang et al. 2021), rotation speed, pH, temperature, and electron transfer (Chang et al. 2020; Zhou et al. 2019a, 2020). However, byproducts were still observed in addition to the designed bioconversion route from phytosterol to the end product.
There are typically two subpathways involved in the side-chain degradation of phytosterol in Mycobacterium (Fig. 1). In addition to the C19-steroid, the C22-steroidal subpathway commonly accumulates 20-hydroxymethyl pregn-4-ene-3-one (4-HBC) and 20-hydroxymethyl pregn-1,4-diene-3-one (1,4-HBC). Some key enzymes are reported to be involved in regulating the metabolic flux distribution between the two subpathways. The 3-ketoacyl-CoA thiolase FadA5 is responsible for the initial step of phytosterol side-chain degradation (Donova and Egorova 2012; Schaefer et al. 2015). Hydroxyacyl-CoA dehydrogenase (Hsd4A) catalyzes the dehydrogenation of 22-hydroxy-3-oxo-cholest-4-ene-24-carboxyl-CoA (22-OH-BNC-CoA) in the second cycle of cholesterol side-chain degradation (Xu et al. 2016). A dual-role reductase (OpccR) was recently reported to catalyze the reduction of 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) and 3-oxo-4-pregnene-20-carboxyl aldehyde (3-OPA) in the production of 4-HBC (Peng et al. 2021). Much attention has been paid to the analysis of metabolic pathways in growing cells (Zhao et al. 2021), while few studies addressed the pathway alterations in resting cells, which are often used as biocatalysts. Clarification of the regulation mechanism underlying the catabolic flow of phytosterol degradation during biotransformation with resting cells is therefore of significant importance, and key node enzymes that may drive the metabolic switch should be considered first. This information may offer insightful ideas for the rational development of mycolicibacterial cell factories to exclusively attain specific products via directed bypass pathway inhibition.
In addition, byproduct accumulation can also be the result of the insufficient activity of rate-limiting enzymes. To develop genetic tools for optimizing biosynthetic pathways, plasmid or genome alterations always require either an adjustment of gene expression or an introduction of heterologous genes, which are regulated by specific promoters and ribosome binding sites (RBS) (Balzer et al. 2013; Englund et al. 2016). Hong et al. constructed a library of 49 ribosomal binding sites (RBS) on the mycobacterial plasmid pMV261, obtaining 38 strong and 11 weak RBS (Sun et al. 2020). Compared with the RBS, the available promoters are relatively simpler and more widely available. The constitutive promoter hsp60 is a popular choice for the overexpression of genes to reinforce biosynthetic pathways (Shao et al. 2019). In contrast to other species of Mycobacterium, there are no available strong promoters for M. neoaurum, which leads to an excessive dependence of heterologous gene expression on multicopy plasmids. However, the resulting metabolic burden will inhibit cell growth, while the lack of suitable antibiotics, especially for long-term transformation with resting cells, will lead to the loss of plasmids. To achieve stable and effective expression of key rate-limiting enzymes in the phytosterol conversion pathway, it is necessary to mine more suitable and stronger promoters as well as to construct a chromosomal integration platform.
In this study, a two-step biotransformation process was adopted using an ADD-producing strain M. neoaurum NRRL B-3805. To investigate the effect of induction with different concentrations of phytosterol on the catabolic switch between the C19- and C22-steroidal subpathways, the expression of putative node enzymes was investigated at the transcriptional level, followed by an analysis of metabolic changes after individual deletion. In addition, promoter engineering as well as overexpression system optimization in M. neoaurum NRRL B-3805 was also performed to remove bottlenecks. Finally, directed inhibition of competing pathways and reinforcement of rate-limiting steps resulted in a strong targeted metabolic flux toward ADD synthesis in resting cells of M. neoaurum NRRL B-3805, resulting in a high molar yield and volumetric productivity.
Materials and methods
Chemicals, strains, and plasmids
The phytosterols (40.50% β-sitosterol, 23.82% campesterol, 24.96% stigmasterol, and 1.07% brassicasterol) were purchased from Cofco Tech Bioengineering Co., Ltd. (Tianjin, China). ADD and 1,4-HBC were obtained from Shanghai Yuanye Bio-Technology Co., Ltd. (Shanghai, China). 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD) was purchased from Sigma-Aldrich Trading Co., Ltd. (Shanghai, China). The DNA polymerase and One-Step Cloning Kit were purchased from Vazyme Biotech Co., Ltd. (Nanjing, China). Restriction enzymes were from Thermo Fisher Scientific (Waltham, Massachusetts, USA). Unless otherwise stated, all other chemicals were obtained from Shanghai Aladdin Bio-Chem Technology Co., LTD, and Sinopharm Chemical Reagent Co., Ltd., China. All strains and plasmids used in this study are listed in Table 1. M. neoaurum NRRL B-3805 is a non-pathogenic industrial host deposited at the German National Resource Centre for Biological Material. The other strains were derived from M. neoaurum NRRL B-3805 through general genetic manipulation. The promoters and RBS sequences used in this study are listed in Table S1. The plasmids and detailed construction processes were constructed with the primers listed in Supplemental Table S2.
Identification of the OpccR isozymes Cdun and aldolase Sal
The sequences of short-chain dehydrogenase Cdun (AMO04762.1) as OpccR putative isozymes and Sal aldolase (CP011022.1) from M. neoaurum NRRL B-3805 were, respectively, performed by amino acid sequence alignments with reported OpccR (QPP46742.1) and Sal (WP_039606914.1) by ClustalX 1.81 software and are listed in Supplementary Material.
Genetic manipulation
DNA was cloned and purified using standard protocols. Overexpression vectors were constructed by cloning PCR product between the BamHI and HindIII sites of the shuttle plasmid pMV261 or the XbaI and HpaI sites of the shuttle plasmid pMV306. The ClonExpress® II One Step Cloning Kit (Vazyme, China) was used for ligated fragments and linearized vectors in E. coli DH5α, and all plasmids were purified from E. coli DH5α and verified by DNA sequencing. The overexpression and integration plasmids were electroporated into the competent mycobacterial cells, and positive transformants were further confirmed by PCR and sequencing.
Targeted genetic deletion in M. neoaurum was performed as described before (Parish and Stoker 2000; Yao et al. 2013). The P2NIL suicide vector was constructed by inserting the PCR product between the PacI and NotI sites. For unmarked gene deletion via homologous recombination in M. neoaurum, the plasmid was first subjected to alkali treatment and UV irradiation and then transferred into the mycobacterial cells by electroporation. After a two-step selection process on kanamycin and sucrose plates, the recombinant strains were confirmed by PCR and sequencing. All the primers used are listed in Supplementary Material.
Quantitative real-time PCR
The RNA was isolated using a FastPure Cell/Tissue Total RNA Isolation Kit, and residual DNA in the sample was removed according to the instructions (Q711, Vazyme, China). Reverse transcription was conducted to obtain cDNA, and qPCR was performed using the ChamQ Universal SYBR qPCR Master Mix. Gene expression was analyzed using the 2−ΔΔCT method (Zhang et al. 2018) with 16S RNA as the internal reference for normalization. Primers were designed online using sequences from the NCBI database and are listed in Supplementary Material.
Measuring signal intensities of recombinant fluorescent strains
Recombinant strains based on NRRL B-3805 expressing the eGFP constructs were growing for 60 h in LB medium with kanamycin. Then, the cells from 1 mL of the bacterial culture were harvested by centrifugation at 2000 g for 1 min, washed with 1 mL of 10 mM K2HPO4 buffer (pH = 7.4) three times, and resuspended in the same buffer. Then, 200 µL aliquots were transferred into a clear-bottomed black 96-well plate (Costar) and the plate was placed in a multifunctional microplate reader (BioTek Synergy H1). Fluorescence was measured at an excitation wavelength of 488 nm and emission wavelength of 528 nm. The fluorescence values were normalized to the respective optical density at 600 nm (OD600) of the cell suspension in each well.
Culture conditions and two-step biotransformation processing
For the preparation of resting cells, the strain was first cultivated in LB medium (50 mL in 250-mL shake flasks) at 30 °C and 180 rpm for 36 h and then transferred to 800-mL M3-Tw medium (KH2PO4 0.5 g/L, K2HPO4 0.5 g/L, (NH4)2HPO4 1.5 g/L, FeSO4·7H2O 0.005 g/L, ZnSO4·7H2O 0.002 g/L, MgSO4·7H2O 0.2 g/L, yeast extract 5 g/L, and glycerol 5 g/L, adjust pH to 7.2, Tween 80 0.05% (v/v)) in 2-L shake flasks with a 2% inoculum size for the main culture (Loraine and Smith 2017). Phytosterol (0, 0.2, 0.5, 1.0 g/L) was added into the M3-Tw medium as an inducer. After 48 h of incubation at 30 °C and 180 rpm, cells were harvested by centrifugation at 2000 g and 4 °C for 10 min. The cell pellets were washed twice with 20 mM Na+-phosphate buffer (pH 8.0) and resuspended in the same buffer to yield the resting cells for further use.
For the biotransformation of phytosterols using the resting cells, the sterol emulsion (100 g/L) was homogenized with HP-β-CD (400 g/L) using dispersion equipment. The bioconversion was performed in a reaction system containing 50 g/L wet cells in 50 mL 20 mM K2HPO4 (pH 8.0) at 30 °C and 180 rpm in a 250-mL shake flask.
Analytical methods
Products were analyzed by high-performance liquid chromatography on a G7115A instrument (Agilent Technologies, American) equipped with a C18 column (250 mm × 4.6 mm, 5 μm; J&K Scientific, China). Methanol and water (80:20, v/v) was used as the mobile phase at 1 mL/min, and a UV detector at 254 nm, 40 °C, was used to detect intermediates.
Statistical analysis
All experiments were performed in triplicates, and the mean values and standard curves calculated from three different batches of data were used in the manuscript. The least significant difference was computed at p < 0.05. The figures were performed using the Origin software version 8.0 (OriginLab Corp., Northampton, MA, USA).
Results
Induction of phytosterol caused a catabolic switch from C22- to C19-steroidal side-chain cleavage in resting cells of NRRL B-3805ΔkshA1
The enzyme activity of 3-ketosteroid-9α-hydroxylases was disrupted by kshA1 deletion to obtain the ADD-producing strain NBΔkshA1. There is an accumulation trend of ADD over time in the biotransformation system, utilizing resting cells of NRRL B-3805 as catalysts, both with and without the deletion of kshA1 (Fig. S1). The main product was ADD and 1,4-HBC, presenting comparatively high dehydrogenase activity of C1,2 in NRRL B-3805. To investigate the effect of phytosterol induction on the catabolic switch within the resting cells of NBΔkshA1, different concentrations of phytosterol (0, 0.2, 0.5, 1.0 g/L) were supplemented into the growth medium as inducer, and the accumulation of both ADD and 1,4-HBC was determined during the biotransformation stage. Compared with the negative control, the molar yield of ADD was increased by 37.4 to 50.5%, as well as 59.9% and 58.8% in the groups induced with 0.2, 0.5, and 1.0 g/L phytosterol, respectively (Fig. 2A). On the other hand, although the accumulation of 1,4-HBC gradually increased during the biotransformation process, a significant reduction in the conversion ratio of 1,4-HBC toward ADD was observed with the increased addition of phytosterol (Fig. 2B). These results indicated that proper addition of phytosterol during the cell growth stage rerouted the catabolic flux into the ADD subpathway, indicating that the corresponding enzyme activities in the C19- and C22-steroidal subpathways may be affected by phytosterol even in the early stage for biomass accumulation. Thus, the molecular mechanism underlining the metabolic switch of phytosterol degradation was further explored.
To confirm the above assumption, transcriptional changes of the genes encoding key enzymes involved in phytosterol catabolism were investigated. Cholesterol oxidases (ChoM2) and 3-ketosteroid-1,2-dehydrogenase (KstD1), respectively, play roles in the initiation of phytosterol degradation and introduction of a C1-C2 double bond in 4-HBC or AD (Rohman et al. 2013; Yao et al. 2013). In addition, the bifunctional protein of both OpccR and Hsd4A, important for the redox reaction of C17 sidechain degradation, was also investigated (Peng et al. 2021; Xu et al. 2016). Recently, the Sal aldolase was confirmed to play a role in side-chain degradation of sterols in Pseudomonas sp. Chol1 (Holert et al. 2013). Further sequence alignment revealed a putative aldolase sequence in the genome of M. neoaurum NRRL B-3805 that shared 58.88% similarity with a homologous Sal (Fig. S3). Aldolases, which belong to the thiolase superfamily, are also essential for the cleavage of the sterol side chain (Holert et al. 2013). The real-time PCR results demonstrated that the transcription of kstD1 choM2 and opccR was sharply upregulated following induction with increased concentrations of phytosterol, while the sal gene was downregulated. The transcriptional level of hsd4A did not exhibit a regular change, indicating that it was not regulated by phytosterol (Fig. 3). The significant upregulation in the transcriptional levels of kstD1 and choM2 reflected the strengthening of the overall metabolic flux in steroid degradation, which was consistent with the increased production of both ADD and 1,4-HBC (Fig. 2A). Moreover, the induction of phytosterol with increased concentrations diverted the end product from 1,4-HBC to ADD, indicating that some key steps might be affected that are involved in the metabolic switch between the C19- and C22-steroidal subpathways. Our data revealed an obvious dose-dependent downregulation of sal, which was not consistent with the change trend of hsd4A (Fig. 3). Notably, the decline of the 1,4-HBC/ADD yield ratio did not coincide with the downregulation of opccR transcription. We speculate that the downregulation of sal led to a reduced supply of the precursor 3-OPA, thus affecting the synthesis of 1,4-HBC. In addition, the expression of related enzymes in the biosynthetic pathway of ADD utilizing 3-OPC-CoA as the common precursor was more significantly upregulated than that of opccR.
Blocking of C22-steroidal subpathway by sequential deletion of opccR and sal
It was reported that OpccR plays an important role in the synthesis of 4-HBC (Peng et al. 2021). To block the C22-steroidal subpathway, opccR was deleted by homologous recombination in the chassis strain NBΔkshA1, resulting in NBΔkshA1/opccR. After deletion of opccR, the yield of ADD increased marginally, from 3.87 to 4.08 g/L. At the same time, the yield of 1,4-HBC decreased from 1.58 to 1.36 g/L after 120 h of biotransformation (Table 2). Although the byproduct titer of 1,4-HBC decreased to some extent, it was still present in the bioconversion system. Based on this result, we speculated that isozymes of OpccR may exist in the genome of NRRL B-3805. As a bifunctional enzyme, putative isozymes corresponding to either the C- or N-terminal domain of OpccR were, respectively, screened using the two virtual probes AGRSIR and DGPY, which were, respectively, designed according to conserved sequences found in the C- and N-terminal domain of OpccR. A total of 26 putative isozymes corresponding to the C-terminal domain mainly designated as “short-chain dehydrogenase” were obtained, named as Cdun, which exhibited the highest similarity of 39.2% (Fig. S2), chosen for further deletion. Unfortunately, 1,4-HBC was still present in the phytosterol biotransformation system using resting cells of NBΔkshA1/opccR/cdun.
At the same time, the putative aldolase Sal with a role in the preceding step of C22 steroidal degradation exhibited a dose-dependent downregulation during ADD bioconversion. Thus, the sal gene was tentatively deleted from the genome of the NBΔkshA1/opccR strain to generate the strain NBΔkshA1/opccR/sal, which no longer produced the byproduct of 1,4-HBC (Fig. 4B), resulting in a significant increase of ADD accumulation. After 120 h of biotransformation, the ADD yield was increased to 4.90 g/L (Table 2), corresponding to a molar yield of 71.3%, which was 70.3% higher than that of the NBΔkshA1/opccR strain (Fig. 4A). This result revealed that the sequential deletion of opccR and sal led to a complete blockage of the C22-steroidal subpathway. Elimination of the C22-steroidal byproduct in C19-steroidal producing strain was recognized as a great challenge in previous studies (Chang et al. 2020; Liu et al. 2018; Wang et al. 2019; Xu et al. 2015), which greatly hampered the downstream processing. This could be due to the incompletely defined catabolism responsible for the truncation of the sterol C17 side chain, which involves a series of reactions analogous to the fatty acid β-oxidation pathway. Our data confirmed that the putative aldolase Sal plays a crucial role in driving the metabolic switch between the C19- and C22-steroidal subpathways. However, due to the difficulties in obtaining the substrate 22-OH-BNC-CoA for in vitro functional characterization, the precise role of Sal in the degradation of the C24 steroidal side chain needs further confirmation.
Characterization and overexpression of rate-limiting step in ADD bioconversion via promoter engineering and genome integration
As there was still a small amount of AD in the biotransformation system using resting cells of NBΔkshA1/opccR/sal (Fig. 4B), we further investigated the pivotal elements in the bioconversion from AD to ADD. To develop genetic tools for optimizing biosynthetic pathways, we sought to screen a series of promoters by comparing their GFP fluorescent intensity. Previous studies found a variety of novel promoters (SMYC, G13, msp12, MOP, left, left*) showed high transcriptional activity in Mycobacterium tuberculosis (Kolbe et al. 2020). However, only the constitutive promoter hsp60 was adopted for overexpression in M. neoaurum in previous studies. Thus, the integrative vector pMV 306 and episomal plasmid pMV 261 were used as backbones to construct expression cassettes encoding the eGFP gene driven by the SMYC, G13, L2, MOP, L1, or hsp60 promoter. As shown in Fig. 5A, all recombinant strains expressing eGFP showed a higher fluorescence intensity than the reference strain NB phsp60-eGFP. The strongest fluorescent intensity was observed in NBpSMYC-eGFP, with a 63-fold increase above that of NBphsp60-eGFP. In addition, electro-transformation with the vectors based on pMV 306 was used to integrate different promoters into the chromosome by site-specific recombination (Fig. 5C). The highest expression level was observed in NBpL2-I-eGFP with an 83-fold increase above that of NBphsp60-eGFP. By contrast, the other recombinant strains including NBpMOP-I-eGFP, NBpSMYC-I-eGFP, NBpG13-I-eGFP, and NBpl1-I -eGFP had similar expression levels to those of NBphsp60-eGFP (Fig. 5). Based on the comparison of fluorescence intensity, pMV261 with SYMC and G13 MOP promoters as well as pMV306 with the L2 promoter were selected for the subsequent overexpression of key genes.
To further strengthen the directed synthesis of ADD, putative rate-limiting enzymes were respectively overexpressed using different promoters in NBΔkshA1-opccR-sal, and a higher phytosterol concentration of 30 g/L was used in the resting cell biotransformation systems. According to the transcriptomic analysis, both kstD1 and choM2 play important roles in the directed bioconversion of ADD (Fig. 3). As shown in Table 3, after 144 h, the ADD yield of NBΔkshA1/opccR/sal-phsp60-kstD1, NBΔkshA1/opccR/sall-pSMYC-kstD1, and NBΔkshA1/opccR/sal-pL2-I-kstD1 reached 13.88, 16.12, and 16.59 g/L, representing increases of 3.73%, 20.48%, and 24.00% compared with NBΔkshA1/opccR/sal, respectively. Moreover, the byproduct yield of AD was also significantly decreased (Table 3). These results demonstrated that overexpression of the kstD1 gene was highly effective for overproducing ADD in NBΔkshA1/opccR/sal. Unfortunately, increasing the copy number of choM2 in NB-ADD, irrespective of the promoter, did not lead to an increase of the ADD yield compared with M. neoaurum NRRL B-3805. Similar results were also obtained with the strain overexpressing hsd4A inserted into the chromosome driven by the promoter L2 (data not shown). This may be due to the sufficient endogenous ChoM2 and Hsd4A for ADD biosynthesis after the strain was induced with 0.5 g/L phytosterol. Unexpectedly, although the fluorescence intensity of strains with MOP and G13 on the pMV261 vector was higher than that of the negative control, the bioconversion ratio was not consistent (Table 3), possibly due to the incompatibility between the corresponding promoter and the host M. neoaurum NRRL B-3805.
Directed biotransformation from phytosterol to ADD by resting cells of engineered M. neoaurum NRRL B-3805
For the efficient bioconversion of highly concentrated phytosterols into ADD, a two-step bioprocess was adopted. In the first step for the preparation of resting cells, the biomass and initial growth rate were significantly reduced in recombinant strains with plasmid-based gene overexpression (NBΔkshA1/opccR/sal-pSMYC-kstD1 and NBΔkshA1/opccR/sal-phsp60-kstD1) compared with the negative control. For example, NBΔkshA1/opccR/sal-pL2- kstD1 remained to have reached the highest OD600 of 9.6 after 36 h of cultivation (Fig. 6A). To overcome growth inhibition due to the metabolic burden of multicopy plasmid expression, chromosomal integration of target genes driven by a strong promoter such as L2 was adopted for the overexpression of rate-limiting enzymes in this study. For the subsequent biotransformation, resting cells were collected and used as the catalyst. As shown in Fig. 6B, the titer of ADD increased dramatically during the biotransformation. In the period of 120 to 144 h, the AD titer sharply decreased and was especially low in strains NBΔkshA1/opccR/sal-pSMYC-kstD1 and NBΔkshA1/opccR/sal-pL2-I-kstD1 (0.91 and 0.78 g/L), representing respective 48.6% and 56.0% reductions compared with NBΔkshA1/opccR/sal. Ultimately, the highest ADD molar yield of 80.5% was obtained with the NBΔkshA1/opccR/sal-pL2-I-kstD1 strain, combined with a space–time productivity of 2.77 g·L−1·day−1. In the subsequent optimization process, bioconversion parameters including the dissolved oxygen and biocatalyst loading as well as substrate concentration on the molar conversion ratio of phytosterol to ADD were, respectively, investigated as shown in Supplementary Material. Under the conditions of 80 g/L wet cell sediment within a liquid volume of 30 mL, the molar biotransformation rate of ADD reached 82.0% and the space–time yield increased from 2.77 to 4.22 g·L−1·day−1 (Fig. S4).
Discussion
The cholesterol biodegradation is primarily regulated by two transcriptional repressors from the TetR family in mycobacteria, known as KstR and KstR2 (Kendall et al. 2010; Ma et al. 2022). Target genes of KstR are involved in cholesterol trans-membrane translocation, side-chain truncation, and degradation of nucleus rings A and B. Meanwhile, KstR2 mainly regulates the expression of genes involved in the degradation of steroid nucleus rings C and D (Zhao et al. 2021). Research on the mechanism of KstR regulation suggests that the endogenous ligands of KstR are thioesters of cholesterol side-chain degradation products, including four steroidal rings and the CoA-esterified side-chain moiety. Ligand binding to KstR relieves its inhibition on DNA binding (Ho et al. 2016). In Nocardioides simplex VKM Ac-2033D, induction with phytosterols resulted in the upregulation of 91 genes and the downregulation of 41 genes, with approximately one-third of the operons being induced (Shtratnikova et al. 2021). These results suggest that phytosterol induction may relieve the inhibition of enzyme expression by ligand binding of the intermediate during phytosterol degradation, composing the similar structure with steroidal rings and a CoA-esterified side chain. According to our results, the addition of phytosterols during the growth stage induced the expression of related enzymes, leading to increased production of C-19 steroids and the C-19/C-22 ratio was largely increased during the biotransformation stage. Changes in transcription levels of key genes in the degradation pathway further supported this hypothesis, indicating that phytosterols can regulate the expression of related genes, similar to the mechanism of action of regulatory factors such as TetR on genetic clusters involved in cholesterol degradation.
Key enzymes with putative dominant role in the metabolic switch between C-19 and C-22 pathway were committed in recent studies. The dual-functional reductase OpccR is thought to be involved in two different metabolic branches of the C-22 pathway (Peng et al. 2021). Deletion of opccR could eliminate 4-HBC in the M. neoaurum CCTCC AB2019054 strain, and overexpression of opccR combined with hsd4A deletion led to the accumulation of 4-HBC as the sole product from phytosterols. Paradoxically, a most recent study showed that opccR deletion in M. neoaurum HGMS2 strain promoted the accumulation of the C-22 steroid intermediate 22-hydroxy-23,24-bisnorchol-4-ene-3-one, confirming that different branches of the phytosterol degradation pathway are present in different actinobacteria (Song et al. 2023). In our results, the effect of opccR deletion on ADD accumulation was not obvious; the byproducts of C-22 steroids could not be completely eliminated in high-yield C-19 steroid strains in previous studies (Chang et al. 2020; Shao et al. 2019). After the deletion of the new identified aldose Sal, the C-22 subpathway was totally abolished in the present work, supporting the target biotransformation from phytosterol to C-19 steroid, a new strategy for the construction of C-19 steroid high-yield strain.
In order to achieve overexpression of rate-limiting enzymes, episomal gene overexpression is commonly adopted using multicopy of plasmid as expression vectors due to the insufficient activity of the constitutive promoter, such as hsp60. In our study, we excavated and engineered novel promoters L2 with high transcriptional activity, which significantly improved the overexpression of target enzymes in M. neoaurum. Additionally, Saviola and Bishai demonstrated the integration of a vector carrying a new attB site into the chromosome of M. smegmatis, allowing the plasmid-borne attB site to serve as a second site for subsequent integration (Saviola and Bishai 2004). The new integrative approach combined with the strong promoter L2 as applicated in the present study enabled a substantial enhancement of the rate-limiting enzyme and resulted in significantly higher molar yields in the engineered cell factory. Co-expression of multiple genes for the construction of other bacterial strains via this strategy could be envisioned in future study. The production of steroid drug intermediates can be increased and the utilization efficiency of phytosterol can be improved by enhancing metabolic flux. Overexpression of choM2 resulted in a 40% increase in ADD production in M. neoaurum NwIB-R10 and a 51.2% increase in AD production in M. neoaurum NwIB-01MS (Yao et al. 2013). However, possibly due to the strong induction effect of phytosterol in growing cells of M. neoaurum NRRL B-3805ΔkshA1-opccR-sal, the endogenous ChoM was already able to efficiently convert phytosterols; therefore, no further improvement in ADD production was observed after choM overexpression. KstD1 plays critical role in the dehydrogenation from AD to ADD. In M. neoaurum ATCC 25795△kshA1/kshA2, the accumulated AD and ADD from phytosterols could be enhanced by overexpressing kstD1, leading to an increased proportion of ADD in the steroid products (Yao et al. 2014). Similarly, in M. neoaurum JC-12, ADD yield could be further enhanced by deleting kshA and overexpressing kstD (Shao et al. 2019). Consistently in our study, the ADD production was also increased in M. neoaurum NRRL B-3805. On the other hand, unexpectedly, overexpression of hsd4A showed significant improvement in the yield of C-19 steroids in previous studies, while it did not yield promising results in our strain. We speculate that this may be due to the disruption of the C-22 pathway after sal deletion, and the endogenous induction of hsd4A itself is sufficient for metabolic flux switch toward the C-19 steroidal subpathway (Liu et al. 2018; Wang et al. 2019). Therefore, no further improvement in ADD production with hsd4A overexpression was observed after sal deletion.
To provide a close resemblance of the industrial application scenario, the molar number of substrates was directly calculated by the initial loading weight of phytosterol in the present study. Phytosterols are complex mixtures of various substances with particles of different diameters. Some insoluble substrate was still observed in the system, especially at high substrate loading, thereby affecting the precise calculation of the molar ratio bioconversion from phytosterol to ADD. Mancilla et al. analyze the effect of the particle size in the biotransformation of phytosterols to AD, and the results show that smaller particles would be suitable for biotransformation (Mancilla et al. 2018). Excluding our efforts on the metabolic engineering for directed biotransformation from phytosterol to ADD, several challenges still remained in the modular optimization of the cell factory, including the cytotoxicity of propionyl-CoA and reactive oxygen species within the cells (Sun et al. 2019; Zhou et al. 2019b), the impact of the thick cell wall of mycobacteria on phytosterol uptake (Abuhammad 2017), and the influence of electron transfer rate on phytosterol degradation (Su et al. 2017; Zhou et al. 2019a). Currently, researchers have proposed corresponding strategies. For example, the deficiency of this gene raised the cell permeability, thereby enhancing the steroid uptake and utilization. The 9α-OH-AD yield in the fbpC3-deficient 9α-OH-AD-producing strain was increased by 21.3% (Xiong et al. 2022). By augmenting catalase CAT and enhancing the synthesis of mycothiol and ergothioneine, the cell viability and the 4-HBC production were enhanced by about 50% (Sun et al. 2019). It is envisioned that a combined optimization of multiplex modular in phytosterol bioconversion system should be performed to maximize the molar yield of steroidal intermediate for industrial applications.
In this study, the catabolic switch of phytosterol degradation between the steroidal C19- and C22-subpathways was investigated in resting cells of M. neoaurum NRRL B-3805, which revealed a dose-dependent transcriptional response of putative node enzymes. The byproduct 1,4-HBC was eliminated after sequential deletion of opccR and sal. Rate-limiting steps were identified and overcome by mining and chromosomal integration of novel strong promoters. The directed biotransformation route developed in this study allowed up to 82.0% molar yield of ADD in the engineered strain, while the enzymes responsible for the catabolic switch as well as the genetic tools provide a new effective method for the directed biotransformation of C19- and C22-steroidal products using phytosterol as the raw material.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Abuhammad A (2017) Cholesterol metabolism: a potential therapeutic target in Mycobacteria. Br J Pharmacol 174(14):2194–2208. https://doi.org/10.1111/bph.13694
Balzer S, Kucharova V, Megerle J, Lale R, Brautaset T, Valla S (2013) A comparative analysis of the properties of regulated promoter systems commonly used for recombinant gene expression in Escherichia coli. Microb Cell Fact 12(1):26. https://doi.org/10.1186/1475-2859-12-26
Chang HX, Zhang HT, Zhu L, Zhang W, You SP, Qi W, Qian JW, Su RX, He ZM (2020) A combined strategy of metabolic pathway regulation and two-step bioprocess for improved 4-androstene-3,17-dione production with an engineered Mycobacterium neoaurum. Biochem Eng J 164
Donova MV, Egorova OV (2012) Microbial steroid transformations: current state and prospects. Appl Microbiol Biotechnol 94(6):1423–1447. https://doi.org/10.1007/s00253-012-4078-0
Donova MV, Gulevskaya SA, Dovbnya DV, Puntus IF (2005) Mycobacterium sp mutant strain producing 9 alpha-hydroxyandrostenedione from sitosterol. Appl Microbiol Biotechnol 67(5):671–678. https://doi.org/10.1007/s00253-004-1808-y
Englund E, Liang FY, Lindberg P (2016) Evaluation of promoters and ribosome binding sites for biotechnological applications in the unicellular cyanobacterium Synechocystis sp PCC 6803. Sci Rep 6(1):36640. https://doi.org/10.1038/srep36640
Fernandez-Cabezon L, Garcia-Fernandez E, Galan B, Garcia JL (2017) Molecular characterization of a new gene cluster for steroid degradation in Mycobacterium smegmatis. Environ Microbiol 19(7):2546–2563. https://doi.org/10.1111/1462-2920.13704
Gupta P, Mahajan A (2019) Sustainable approaches for steroid synthesis. Environ Chem Lett 17(2):879–895. https://doi.org/10.1007/s10311-018-00845-x
Ho NAT, Dawes SS, Crowe AM, Casabon I, Gao C, Kendall SL, Baker EN, Eltis LD, Lott JS (2016) The structure of the transcriptional repressor KstR in complex with CoA thioester cholesterol metabolites sheds light on the regulation of cholesterol catabolism in Mycobacterium tuberculosis. J Biol Chem 291(14):7256–7266. https://doi.org/10.1074/jbc.M115.707760
Holert J, Jagmann N, Philipp B (2013) The essential function of genes for a hydratase and an aldehyde dehydrogenase for growth of Pseudomonas sp strain Chol1 with the steroid compound cholate indicates an aldolytic reaction step for deacetylation of the side chain. J Bacteriol 195(15):3371–3380. https://doi.org/10.1128/jb.00410-13
Kendall SL, Burgess P, Balhana R, Withers M, ten Bokum A, Lott JS, Gao C, Uhia-Castro I, Stoker NG (2010) Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2. Microbiology 156:1362–1371. https://doi.org/10.1099/mic.0.034538-0
Kolbe K, Bell AC, Prosser GA, Assmann M, Yang HJ, Forbes HE, Gallucci S, Mayer-Barber KD, Boshoff HI, Barry CE (2020) Development and optimization of chromosomally-integrated fluorescent Mycobacterium tuberculosis reporter constructs. Front Microbiol 11–2020. https://doi.org/10.3389/fmicb.2020.591866
Kreit J (2019) Aerobic catabolism of sterols by microorganisms: key enzymes that open the 3-ketosteroid nucleus. FEMS Microbiol Lett 366(14) https://doi.org/10.1093/femsle/fnz173
Liu HH, Xu LQ, Yao K, Xiong LB, Tao XY, Liu M, Wang FQ, Wei DZ (2018) Engineered 3-ketosteroid 9 alpha-hydroxylases in Mycobacterium neoaurum: an efficient platform for production of steroid drugs. Appl Environ Microbiol 84(14):e02777–17. https://doi.org/10.1128/aem.02777-17
Loraine JK, Smith MCM (2017) Genetic techniques for manipulation of the phytosterol biotransformation strain Mycobacterium neoaurum NRRL B-3805. In: Barredo JL, Herraiz I (eds) Microbial steroids: methods and protocols. Methods Mol Biol vol 1645, pp 93–108
Ma H, Liu WB, Zhang XP, Hu HQ, Gu SD, Yuan H, Ye BC (2022) GlnR-mediated regulation of KstR controls cholesterol catabolism in Mycobacterium smegmatis. Biotechnol Appl Biochem 69(3):1209–1216. https://doi.org/10.1002/bab.2197
Mancilla RA, Little C, Amoroso A (2018) Efficient bioconversion of high concentration phytosterol microdispersion to 4-androstene-3,17-dione (AD) by Mycobacterium sp B3805. Appl Biochem Biotechnol 185(2):494–506. https://doi.org/10.1007/s12010-017-2665-3
Parish T, Stoker NG (2000) Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology-Sgm 146:1969–1975. https://doi.org/10.1099/00221287-146-8-1969
Peng HD, Wang YY, Jiang K, Chen XR, Zhang WL, Zhang YA, Deng ZX, Qu XD (2021) A dual role reductase from phytosterols catabolism enables the efficient production of valuable steroid precursors. Angew Chem Int Ed 60(10):5414–5420. https://doi.org/10.1002/anie.202015462
Rohman A, van Oosterwijk N, Thunnissen A, Dijkstra BW (2013) Crystal structure and site-directed mutagenesis of 3-ketosteroid delta(1)-dehydrogenase from Rhodococcus erythropolis SQ1 explain its catalytic mechanism. J Biol Chem 288(49):35559–35568. https://doi.org/10.1074/jbc.M113.522771
Saviola B, Bishai WR (2004) Method to integrate multiple plasmids into the mycobacterial chromosome. Nucleic Acids Res 32(1):e11. https://doi.org/10.1093/nar/gnh005
Schaefer CM, Lu R, Nesbitt NM, Schiebel J, Sampson NS, Kisker C (2015) FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis. Structure 23(1):21–33. https://doi.org/10.1016/j.str.2014.10.010
Shao ML, Zhang X, Rao ZM, Xu MJ, Yang TW, Xu ZH, Yang ST (2019) Identification of steroid C27 monooxygenase isoenzymes involved in sterol catabolism and stepwise pathway engineering of Mycobacterium neoaurum for improved androst-1,4-diene-3,17-dione production. J Ind Microbiol Biotechnol 46(5):635–647. https://doi.org/10.1007/s10295-018-02135-5
Shtratnikova VY, Schelkunov MI, Fokina VV, Bragin EY, Shutov AA, Donova MV (2021) Different genome-wide transcriptome responses of Nocardioides simplex VKM Ac-2033D to phytosterol and cortisone 21-acetate. BMC Biotechnol 21(1):7. https://doi.org/10.1186/s12896-021-00668-9
Song SK, He JX, Gao M, Huang YQ, Cheng XY, Su ZD (2023) Loop pathways are responsible for tuning the accumulation of C19-and C22-sterol intermediates in the mycobacterial phytosterol degradation pathway. Microb Cell Fact 22(1):19. https://doi.org/10.1186/s12934-022-02008-8
Su LQ, Shen YB, Xia ML, Shang ZH, Xu SP, An XJ, Wang M (2018) Overexpression of cytochrome p450 125 in Mycobacterium: a rational strategy in the promotion of phytosterol biotransformation. J Ind Microbiol Biotechnol 45(10):857–867. https://doi.org/10.1007/s10295-018-2063-z
Su LQ, Shen YB, Zhang WK, Gao T, Shang ZH, Wang M (2017) Cofactor engineering to regulate NAD(+)/NADH ratio with its application to phytosterols biotransformation. Microb Cell Fact 16(1):182. https://doi.org/10.1186/s12934-017-0796
Sukhodolskaya GV, Nikolayeva VM, Khomutov SM, Donova MV (2007) Steroid-1-dehydrogenase of Mycobacterium sp VKM Ac-1817D strain producing 9 alpha-hydroxy-androst-4-ene-3,17-dione from sitosterol. Appl Microbiol Biotechnol 74(4):867–873. https://doi.org/10.1007/s00253-006-0728-4
Sun WJ, Wang L, Liu HH, Liu YJ, Ren YH, Wang FQ, Wei DZ (2019) Characterization and engineering control of the effects of reactive oxygen species on the conversion of sterols to steroid synthons in Mycobacterium neoaurum. Metab Eng 56:97–110. https://doi.org/10.1016/j.ymben.2019.09.004
Sun H, Yang JL, Song H (2020) Engineering mycobacteria artificial promoters and ribosomal binding sites for enhanced sterol production. Biochem Eng J 162
Wang XD, Hua CL, Xu XW, Wei DZ (2019) Two-step bioprocess for reducing nucleus degradation in phytosterol bioconversion by Mycobacterium neoaurum NwIB-R10(hsd4A). Appl Biochem Biotechnol 188(1):138–146. https://doi.org/10.1007/s12010-018-2895-z
Xiong LB, Liu HH, Song L, Dong MM, Ke J, Liu YJ, Liu K, Zhao M, Wang FQ, Wei DZ (2022) Improving the biotransformation efficiency of soybean phytosterols in Mycolicibacterium neoaurum by the combined deletion of fbpC3 and embC in cell envelope synthesis. Synth Syst Biotechnol 7(1):453–459. https://doi.org/10.1016/j.synbio.2021.11.007
Xiong LB, Liu HH, Zhao M, Liu YJ, Song L, Xie ZY, Xu YX, Wang FQ, Wei DZ (2020) Enhancing the bioconversion of phytosterols to steroidal intermediates by the deficiency of kasB in the cell wall synthesis of Mycobacterium neoaurum. Microb Cell Fact 19(1):80. https://doi.org/10.1186/s12934-020-01335-y
Xu XW, Gao XQ, Feng JX, Wang XD, Wei DZ (2015) Influence of temperature on nucleus degradation of 4-androstene-3, 17-dione in phytosterol biotransformation by Mycobacterium sp. Lett Appl Microbiol 61(1):63–68. https://doi.org/10.1111/lam.12428
Xu LQ, Liu YJ, Yao K, Liu HH, Tao XY, Wang FQ, Wei DZ (2016) Unraveling and engineering the production of 23,24-bisnorcholenic steroids in sterol metabolism. Sci Rep 6:21928. https://doi.org/10.1038/srep21928
Yao K, Wang FQ, Zhang HC, Wei DZ (2013) Identification and engineering of cholesterol oxidases involved in the initial step of sterols catabolism in Mycobacterium neoaurum. Metab Eng 15:75–87. https://doi.org/10.1016/j.ymben.2012.10.005
Yao K, Xu LQ, Wang FQ, Wei DZ (2014) Characterization and engineering of 3-ketosteroid-Delta(1)-dehydrogenase and 3-ketosteroid-9 alpha-hydroxylase in Mycobacterium neoaurum ATCC 25795 to produce 9 alpha-hydroxy-4-androstene-3,17-dione through the catabolism of sterols. Metab Eng 24:181–191. https://doi.org/10.1016/j.ymben.2014.05.005
Zhang RJ, Liu XC, Wang YS, Han YC, Sun JS, Shi JP, Zhang BG (2018) Identification, function, and application of 3-ketosteroid Delta l -dehydrogenase isozymes in Mycobacterium neoaurum DSM 1381 for the production of steroidic synthons. Microb Cell Fact 17(1):77. https://doi.org/10.1186/s12934-018-0916-9
Zhang Y, Zhou XL, Yao YY, Xu QQ, Shi HY, Wang KM, Feng W, Shen YB (2021) Coexpression of VHb and MceG genes in Mycobacterium sp. strain LZ2 enhances androstenone production via immobilized repeated batch fermentation. Bioresour Technol 342:125965. https://doi.org/10.1016/j.biortech.2021.125965
Zhao AQ, Zhang XQ, Li YM, Wang Z, Lv YK, Liu JL, Alam MA, Xiong WL, Xu JL (2021) Mycolicibacterium cell factory for the production of steroid-based drug intermediates. Biotechnol Adv 53:107860. https://doi.org/10.1016/j.biotechadv.2021.107860
Zhou XL, Zhang Y, Shen YB, Zhang X, Xu SP, Shang ZH, Xia ML, Wang M (2019a) Efficient production of androstenedione by repeated batch fermentation in waste cooking oil media through regulating NAD(+) /NADH ratio and strengthening cell vitality of Mycobacterium neoaurum. Bioresour Technol 279:209–217. https://doi.org/10.1016/j.biortech.2019.01.144
Zhou XL, Zhang Y, Shen YB, Zhang X, Zhang ZJ, Xu SP, Luo JM, Xia ML, Wang M (2019b) Economical production of androstenedione and 9 alpha-hydroxyandrostenedione using untreated cane molasses by recombinant mycobacteria. Bioresour Technol 290:121750. https://doi.org/10.1016/j.biortech.2019.121750
Zhou XL, Zhang Y, Shen YB, Zhang X, Zan ZH, Xia ML, Luo JM, Wang M (2020) Efficient repeated batch production of androstenedione using untreated cane molasses by Mycobacterium neoaurum driven by ATP futile cycle. Bioresour Technol 309:123307. https://doi.org/10.1016/j.biortech.2020.123307
Funding
This work was supported by the Program of the National Key Research and Development Program of China (2019YFA0905300) and Zhejiang Provincial Natural Science Foundation of China (LY23C010004).
Author information
Authors and Affiliations
Contributions
XK: conceptualization, methodology, validation, and writing. JC: experiment, methodology, software, and writing. QR: writing, methodology, software, and validation. TZ: methodology and validation. XW: mining of putative node enzymes. ZL: project administration, funding acquisition, supervision, and conceptualization. YZ: project administration, funding acquisition, and supervision.
Corresponding author
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ke, X., Cui, JH., Ren, QJ. et al. Rerouting phytosterol degradation pathway for directed androst-1,4-diene-3,17-dione microbial bioconversion. Appl Microbiol Biotechnol 108, 186 (2024). https://doi.org/10.1007/s00253-023-12847-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00253-023-12847-z